| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/07/2005 | WO2005031303A2 Soluble phospholipids for use in clotting factor assays |
| 04/07/2005 | WO2005031302A2 Drug authentication |
| 04/07/2005 | WO2005031299A2 Sensor platform using a non-horizontally oriented nanotube element |
| 04/07/2005 | WO2005031003A1 Mutations in wnt-frizzled signaling pathways associated with osteoarthritis |
| 04/07/2005 | WO2005031001A2 Novel therapeutic targets in cancer |
| 04/07/2005 | WO2005031000A2 Treating neuropathic pain with neuropeptide ff receptor 2 agonists |
| 04/07/2005 | WO2005030990A1 Quantification schemes for quantifying nucleic acids |
| 04/07/2005 | WO2005030989A1 Method of in situ detection of proteins using aptamers |
| 04/07/2005 | WO2005030988A1 Method of predicting and/or modifying conversion potential of embryogenic tissues of plants |
| 04/07/2005 | WO2005030985A2 Use of amino acid sequences involved in the elongation of fatty acids in identifying and/or developing compounds for preventing and/or treating metabolic diseases |
| 04/07/2005 | WO2005030981A2 Homogeneous populations of molecules |
| 04/07/2005 | WO2005030979A2 Dark quenchers for fluorescence resonance energy transfer (fret) in bioassays |
| 04/07/2005 | WO2005030961A1 Novel nerve stem cell marker |
| 04/07/2005 | WO2005030955A1 Protein expressed in nk cell |
| 04/07/2005 | WO2005030954A1 Process for producing antigenic substance |
| 04/07/2005 | WO2005030953A1 Tetrahydrofolate synthase gene |
| 04/07/2005 | WO2005030952A1 Method of analyzing haplotype |
| 04/07/2005 | WO2005030947A2 Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases |
| 04/07/2005 | WO2005030805A1 Novel protein complex and use thereof |
| 04/07/2005 | WO2005030802A2 Antigens for an east coast fever vaccine |
| 04/07/2005 | WO2005030695A1 Conversion of amine- to carboxyl groups on solid surfaces |
| 04/07/2005 | WO2005030269A1 Endotoxin-nonresponsive model animal |
| 04/07/2005 | WO2005030256A1 INHIBITION OF NERVE CELL DEATH BY INHIBITING DEGRADATION OF SHC3, ATF6 OR CREBL1 BY HtrA2 AND METHOD OF AMELIORATING NEURODEGENERATIVE DISEASES |
| 04/07/2005 | WO2005030241A2 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 04/07/2005 | WO2005030119A2 Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
| 04/07/2005 | WO2005030051A1 Method and device for using a multi-channel measurement signal in determining the current distribution of an object |
| 04/07/2005 | WO2005030040A2 Hematopoietic stem cell identification and isolation |
| 04/07/2005 | WO2005030033A2 Fluid sample test device |
| 04/07/2005 | WO2005030032A2 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes |
| 04/07/2005 | WO2005030028A2 Methods for detecting presence of cellular constituents |
| 04/07/2005 | WO2005015204A3 Diagnostics and therapeutics for diseases associated with organic anion transporter ust3 like 3 (ust3 like 3) |
| 04/07/2005 | WO2005015190A8 Method and arrangement for detecting substances by means of regulation of an electrical resistance of a sensor |
| 04/07/2005 | WO2005013947A3 Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer |
| 04/07/2005 | WO2005010168A3 Method and system for detecting chloramphenicol |
| 04/07/2005 | WO2005009510A3 Penetration enhancer combinations for transdermal delivery |
| 04/07/2005 | WO2005005988A3 Dosing teichoic acids of gram+ bacteria |
| 04/07/2005 | WO2005005978A3 Fluorine nmr spectroscopy for biochemical screening |
| 04/07/2005 | WO2005005601A8 Compositions and methods for treating and diagnosing cancer |
| 04/07/2005 | WO2004114081A3 Methods and systems for creation of a coherence database |
| 04/07/2005 | WO2004111608A3 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 04/07/2005 | WO2004108948A3 Systems, methods and kits for characterizing phosphoproteomes |
| 04/07/2005 | WO2004106940A3 Relaxin as an independent risk factor predicting mortality |
| 04/07/2005 | WO2004102152A3 Improved porous device |
| 04/07/2005 | WO2004096988A3 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | WO2004094600A3 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 04/07/2005 | WO2004092207A3 Respiratory syncytial virus (rsv) peptides |
| 04/07/2005 | WO2004089369A3 Methods and means for treating protein conformational disorders |
| 04/07/2005 | WO2004083405A3 Separation and accumulation of subcellular components, and proteins derived therefrom |
| 04/07/2005 | WO2004074446A3 Parkin interacting polypeptides and methods of use |
| 04/07/2005 | WO2004063710A8 Mark-pap system (method, kit, solution & accessories) processes for producing and using the same |
| 04/07/2005 | WO2004062462A8 Monclonal anitbodies to rna binding protein gw182 |
| 04/07/2005 | WO2004058055A3 Method and system for disease detection using marker combinations |
| 04/07/2005 | WO2004046732A8 Methods for screening compounds modulating cholesterol flux and uses thereof |
| 04/07/2005 | WO2004025299A8 Generation of chemiluminescence by hydrogen |
| 04/07/2005 | WO2004022005A3 Regulation of the growth hormone/igf-1 axis |
| 04/07/2005 | WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 04/07/2005 | WO2004003234A3 A system and method for snp genotype clustering |
| 04/07/2005 | WO2004001072A3 Method for diagnosis of colorectal tumors |
| 04/07/2005 | WO2003083443A3 Lipid mediated screening of drug candidates for identification of active compounds |
| 04/07/2005 | WO2003062395A3 Predictor sets for tyrosine kinase pathways |
| 04/07/2005 | WO2003058234A9 Method for identifying substances, which are marked with deuterated water and whose hydrogen and oxygen isotope ratios are determined by means of mass spectroscopy |
| 04/07/2005 | WO2003050290A3 Phosphoromonothioate and phosphorodithioate oligonucleotide aptamer chip for functional proteomics |
| 04/07/2005 | WO2003030612A3 Methods for modulating activity of the fxr nuclear receptor |
| 04/07/2005 | WO2001088089A8 Single copy genomic hybridization probes and method of generating same |
| 04/07/2005 | US20050076406 Plant-derived resistance gene |
| 04/07/2005 | US20050076398 Lysine starve rodent model for identifying modulators for treartment and prevention of gastrointestinal disorders |
| 04/07/2005 | US20050076190 Method for the manipulation, storage, modeling, visualization and quantification of datasets |
| 04/07/2005 | US20050075794 Computerized method and system for inferring genetic findings for a patient |
| 04/07/2005 | US20050075793 Computerized system and method for documenting and presenting mutation observations |
| 04/07/2005 | US20050075792 Programmable and autonomous computing machine made of biomolecules |
| 04/07/2005 | US20050075552 Device and method for determining the amount of hemoglobin by means of inhalation of a predefined amount of carbon monoxide |
| 04/07/2005 | US20050075511 Prevention of human and/or animal viral, bacterial, fungal or parasitic infections; plant fungicides, bactericides and/or herbicides; reduced side effects; environmentally friendly; such as ((n-formyl-n-hydroxyamino)-methoxy)-methyl phosphonic acid disodium salt |
| 04/07/2005 | US20050075495 Probes for chondrogenesis |
| 04/07/2005 | US20050075494 Nucleotide sequences coding orphan receptor for use as tools in diagnosis , prevention and treatment of nervous system and psychotic disorders |
| 04/07/2005 | US20050075489 DSP-5 dual-specificity phosphatase |
| 04/07/2005 | US20050075301 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 04/07/2005 | US20050075274 Method for simulating the interaction of chemical compounds with live organisms |
| 04/07/2005 | US20050074970 Mis hydrogen sensors |
| 04/07/2005 | US20050074904 Biosensor which utilizes magnetic fields to detect pathogens in food |
| 04/07/2005 | US20050074903 Assay method using biochemical analysis units and assay apparatus |
| 04/07/2005 | US20050074902 Preparing antinuclear antibodies for monitoring concentrations and activity of nuclear proteins |
| 04/07/2005 | US20050074901 Using p53 inducible gene (PIG3) protein specific antibodies to monitor cell viability, evaluate drug efficacy, and diagnose cell proliferative disorders |
| 04/07/2005 | US20050074900 Microfluidic flow-through immunoassay for simultaneous detection of multiple proteins in a biological sample |
| 04/07/2005 | US20050074899 Method and apparatus for performing a lateral flow assay |
| 04/07/2005 | US20050074895 analysis of protein expression by the reaction of proteins with alkyl-substituted vinyl pyridines as thiol alkylating agents; mass difference is considerably greater than that achieved by isotope tagging |
| 04/07/2005 | US20050074894 Reference control for optical measurement of nucleated red blood cells of a blood sample |
| 04/07/2005 | US20050074893 Using centrifugation and oxidation-reduction potentials to determine glucuose, lactic acid and/or pyruvic acid concentrations in mammalian erythrocytes |
| 04/07/2005 | US20050074888 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 04/07/2005 | US20050074884 Identification of peptides that facilitate uptake and cytoplasmic and /or nuclear transport of proteins, DNA and viruses |
| 04/07/2005 | US20050074882 Using immunoglobulin specific to human leukocyte antigen receptor to modify mitochondrial metabolism and kill tumor cells; immunotherapy; antitumor agents |
| 04/07/2005 | US20050074874 Unique properties of a stem cells |
| 04/07/2005 | US20050074871 Bridged element for detection of a target substance |
| 04/07/2005 | US20050074870 Apparatuses and methods for reducing albumin in samples |
| 04/07/2005 | US20050074869 Using directionally opposite fluid dispension to position preferential cells on sollid support; electrochemical analysis of cell activity |
| 04/07/2005 | US20050074861 Human secretory type phospholipase A2 |
| 04/07/2005 | US20050074853 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 04/07/2005 | US20050074852 Serine/threonine kinase (PKN) peptides for use in identifying modulators for treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074839 Novel survivin interacting protein tpr1 |